ID

30538

Description

Study part: Local Laboratory- Clinical Chemistry (Lab C)- Screening. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.

Keywords

Versions (1)
  1. 6/12/18 6/12/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

June 12, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Local Laboratory- Clinical Chemistry (Lab C)- Screening Pazopanib Macular Degeneration MD1103367

English

Local Laboratory- Clinical Chemistry (Lab C)- Screening

1 forms  
CLINICAL CHEMISTRY
Description

CLINICAL CHEMISTRY

Alias
UMLS CUI-1
C0008000
Back to the top of the page

Similar models

Local Laboratory- Clinical Chemistry (Lab C)- Screening

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
CLINICAL CHEMISTRY
C0008000 (UMLS CUI-1)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial